Searched for
ZYCOV D
Covaxin gets nod for use in kids above 12In October 2021, the Subject Expert Committee of the Central Drugs Standard Control Organisation (CDSCO), which evaluates vaccine applicati...- Zydus Cadila's ZyCov-D shot to soon join other vaccines in India's Covid fightThe drug regulator had on August 20 given emergency use authorisation (EUA) to the three-dose Covid-19 vaccine, the first in India that can...
- Zydus Cadila's Covid vaccine to be administered only to adults as of now: SourcesZydus Cadila's COVID-19 vaccine ZyCov-D, which has been cleared by India's drug regulator for those aged 12 years and above, will only be a...
- Zydus Cadila to supply 1 crore doses of ZyCoV-D to govt at Rs 265/doseZydus Cadila will supply 1 crore doses of its vaccine ZyCoV-D, the world's first plasmid DNA vaccine to the government of India at Rs 265 p...
- Zydus Cadila to get clarity on ZyCoV-D Covid vaccine pricing in 1-2 weeks: MD Sharvil PatelOn Sunday, news wire PTI reported, citing government sources, that the company had agreed to bring down the price of ZyCov-D to ₹265 a dose...
- Zydus Cadila agrees to reduce its Covid vaccine price to Rs 265 a dose, final decision soon: SourcesThe indigenously developed world's first DNA-based needle-free COVID-19 vaccine ZyCoV-D received emergency use authorisation from the drug ...
- India says government panel looking into new Delta subvariantA panel of experts set up by the Indian government is looking into a Delta coronavirus subvariant that has been detected in the UK
- Apollo Hospitals to offer free COVID shots for kids with comorbidities"It is anticipated that approval will soon be granted for vaccinating children with specified co-morbidities and immediately post-approval ...
- Govt expert panel recommends emergency use authorisation for Covaxin in 2 to 18 age groupThe indigenous vaccine, if cleared, will be administered to children between the age-group of 2-18 and will provide a major boost to the co...
- Zydus Cadila proposes Rs 1900 for three-dose COVID vaccine; Govt negotiating to bring it downThe government had on Thursday said that the indigenously-developed, world's first DNA-based needle-free COVID-19 vaccine by Zydus Cadila w...
- Children with comorbidities between ages 12 and 17 may get vaccine by October-NovemberThe government is planning to get children with comorbidities the vaccine by October or November. Children between the ages of 12 and 17, w...
- Government may earmark a part of Zydus vaccine for sick kidsThe drug regulator had last week approved ZyCov-D, the world’s first DNA-based vaccine against the novel coronavirus, for emergency use in ...
- Zydus Cadila expects to meet 50 million Covid vaccine target by JanuaryThe three-dose ZyCov-D is the world’s first DNA-based vaccine approved for use against the disease. It’s also the first in India that can b...
- Cheers, Zydus-Cadila! Speed Up StudiesNow India must leverage this capacity for its growth and for the greater good. The vaccination rate in poor countries is barely at 2%. Ramp...
- ZyCov-D vaccine will hit markets soon: Union health ministerThe company's indigenously developed needle-free three-dose COVID-19 vaccine ZyCoV-D was granted emergency use authorisation (EUA) by the d...
- India to take up Zydus’ COVID vaccine EUA applicationIndia’s drug regulatory authority is likely to take up Zydus Cadila's application seeking Emergency Use Authorisation (EUA) for its Covid-1...
- Zydus vaccine under close review, approval likely to get delayedZydus had applied for emergency use authorisation (EUA) for its vaccine on July 1, but it is yet to be taken up by the subject expert commi...
- Zydus Cadila's vaccine for kids above 12 to come up for approval this weekThe drug regulator will consider emergency use approval for Covid vaccines developed by Zydus Cadila for children above 12 this week. The r...
- India orders 14.5 million more Covid-19 vaccine doses as campaign expandsJust the two shots have been used in what India calls the world's biggest immunisation programme to cover 300 million people by August, sta...
- Zydus Cadila aims to complete trial of coronavirus vaccine by March: Chairman Pankaj PatelCadila's vaccine candidate, known as ZyCov-D, is one of dozens being developed around the world to fight the coronavirus pandemic.
Load More
